Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Adma Biologics Inc (NASDAQ: ADMA) closed at $18.89 down -7.40% from its previous closing price of $20.40. In other words, the price has decreased by -$7.40 from its previous closing price. On the day, 5.97 million shares were traded.
Ratios:
For a deeper understanding of Adma Biologics Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 62.97 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.75. For the most recent quarter (mrq), Quick Ratio is recorded 3.36 and its Current Ratio is at 6.58. In the meantime, Its Debt-to-Equity ratio is 0.22 whereas as Long-Term Debt/Eq ratio is at 0.22.
On October 13, 2022, Mizuho started tracking the stock assigning a Buy rating and target price of $5.
Raymond James Upgraded its Outperform to Strong Buy on November 11, 2021, while the target price for the stock was maintained at $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jun 16 ’25 when ELMS STEVE sold 194,749 shares for $20.24 per share. The transaction valued at 3,941,720 led to the insider holds 87,330 shares of the business.
ELMS STEVE sold 137,931 shares of ADMA for $2,871,723 on Jun 13 ’25. The Director now owns 282,079 shares after completing the transaction at $20.82 per share. On Jun 12 ’25, another insider, ELMS STEVE, who serves as the Director of the company, sold 92,941 shares for $21.69 each. As a result, the insider received 2,015,890 and left with 2,031,730 shares of the company.
Valuation Measures:
As of this moment, Adma’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.38, and their Forward P/E ratio for the next fiscal year is 19.21. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.55. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.82 while its Price-to-Book (P/B) ratio in mrq is 12.07.
Stock Price History:
Over the past 52 weeks, ADMA has reached a high of $25.67, while it has fallen to a 52-week low of $10.21. The 50-Day Moving Average of the stock is -9.46%, while the 200-Day Moving Average is calculated to be 0.35%.
Shares Statistics:
A total of 238.53M shares are outstanding, with a floating share count of 230.42M. Insiders hold about 3.48% of the company’s shares, while institutions hold 86.39% stake in the company.
